- Home
- KOS vs MANE Comparison
KOS vs MANE Comparison
Compare KOS & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KOS | MANE |
|---|---|---|
| Founded | 2003 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | KOS | MANE |
|---|---|---|
| Price | $3.06 | $101.57 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $1.91 | ★ $83.33 |
| AVG Volume (30 Days) | ★ 14.1M | 694.5K |
| Earning Date | 05-05-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,288,352,000.00 | N/A |
| Revenue This Year | $27.11 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.84 | $36.26 |
| 52 Week High | $3.34 | $117.71 |
Technical Indicators
Market Signals| Indicator | KOS | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 53.26 | 56.54 |
| Support Level | $2.73 | $54.23 |
| Resistance Level | $3.09 | $117.71 |
| Average True Range (ATR) | 0.19 | 7.13 |
| MACD | -0.01 | -1.88 |
| Stochastic Oscillator | 53.66 | 26.61 |
Price Performance
Historical ComparisonAbout KOS Kosmos Energy Ltd. (DE)
Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.